Fig. 4From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationMacrostates of VC and percentage of drug available at varying pKa values. The red-coloured values were for the macro-constantsBack to article page